Status:
COMPLETED
Neurosurgical Use of Interstitial Laser Therapy (ILT)
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The researchers' specific aims are to test the following hypotheses: Hypothesis 1: A tumor can be completely ablated by ILT with MRI-guidance. Hypothesis 2: The MRI-based 3D temperature map of tissu...
Detailed Description
The goal is to evaluate the use of minimally invasive interstitial laser therapy (ILT) in the brain. Our group is in a unique position to offer image-guided ILT because of our expertise and resources ...
Eligibility Criteria
Inclusion
- Male or female
- Age 18+
- Surgically difficult to access tumors including intracerebral metastases
Exclusion
- Patients unwilling or unable to give written consent
- Patients at risk for cardiac ischemia
- Patients who cannot physically fit in the MRI scanner in the MRI OR
- Patients with contraindications to MRI imaging such as pacemakers, non-compatible aneurysm clips, shrapnel, and other internal ferromagnetic objects
- Patients with coagulopathies, severe medical problems, cardiac arrhythmias or abnormal BUN
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00207350
Start Date
January 1 2002
End Date
December 1 2006
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham & Women's Hospital
Boston, Massachusetts, United States, 02155